- Free from Publisher A Avignon, A Sultan, C Piot, S Elaerts, JP … - Diabetes Care, 2005 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—This is a nested case-control study; 162
asymptomatic type 2 diabetic patients were evaluated for silent myocardial
ischemia using stress myocardial perfusion imaging; of 50 patients with ... Cited by 42 - Related articles - BL Direct - All 5 versions
- ►eje.org [PDF] ST Knudsen, CH Foss, PL Poulsen, NH … - European Journal of Endocrinology, 2003 - eje.org Objective: Osteoprotegerin (OPG) is a newly identified inhibitor of bone
resorption. Recent studies indi- cate that OPG also acts as an important
regulatory molecule in the vasculature. Plasma levels of OPG seem to be ... Cited by 63 - Related articles - BL Direct - All 8 versions
EJ Rhee, WY Lee, SY Kim, BJ Kim, KC Sung, … - Clinical Science, 2005 - submit.clinsci.org OPG (osteoprotegerin) is an inhibitor of osteoclastogenesis and recent work
suggests it has a role in atherosclerosis. Therefore we measured serum OPG
levels in patients with coronary artery disease, compared the serum OPG ... Cited by 33 - Related articles - Cached - All 11 versions
- ►onlinejacc.org DV Anand, A Lahiri, E Lim, D Hopkins, R … - Journal of the American College of Cardiology, 2006 - Elsevier This study sought to prospectively evaluate the relationship between plasma
osteoprotegerin (OPG), inflammatory biomarkers (high-sensitivity C-reactive
protein [hs-CRP], interleukin-6 [IL-6], coronary artery calcification ... Cited by 53 - Related articles - BL Direct - All 7 versions
- ►eje.org LM Rasmussen, L Tarnow, TK Hansen, HH … - European journal of endocrinology, 2006 - eje.org Results: The plasma OPG concentration was significantly higher in patients with
nephropathy than those without (3.11 (2.49–3.99) vs 2.57 (2.19–3.21) (median
(interquartiles), ng/ml), P < 0.001). Plasma OPG correlated with ... Cited by 37 - Related articles - BL Direct - All 8 versions
- ►endojournals.org M Schoppet, AM Sattler, JR Schaefer, M … - Journal of Clinical Endocrinology & Metabolism, 2003 - Endocrine Soc Osteoprotegerin (OPG) regulates osteoclast and immune functions and appears to
represent a protective factor for the vascular system. However, the role of OPG
in human atherosclerosis has not been evaluated. In this study, we assessed ... Cited by 172 - Related articles - BL Direct - All 5 versions
- ►onlinejacc.org [PDF] T Ueland, R Jemtland, K Godang, J Kjekshus, A … - Journal of the American College of Cardiology, 2004 - Elsevier We assayed plasma OPG levels in 234 patients with AMI complicated with HF and
their relation to adverse outcomes during follow-up in patients randomly
assigned to angiotensin-converting enzyme inhibition or angiotensin II ... Cited by 83 - Related articles - BL Direct - All 16 versions
- ►ahajournals.org [PDF] S Kiechl, G Schett, G Wenning, K Redlich, M … - Circulation, 2004 - Am Heart Assoc Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone:
410-528-4050. Permissions: Permissions & Rights Desk, Lippincott Williams &
Wilkins, a division of Wolters ... Osteoprotegerin Is a Risk Factor for ... Cited by 169 - Related articles - All 9 versions
P Olesen, T Ledet, LM Rasmussen - Diabetologia, 2005 - Springer Abstract Aims/hypothesis: Extracellular matrix modifi- cations and linear medial
calcifications are elements of diabetic macroangiopathy. We hypothesised that
the bone- related protein osteoprotegerin (OPG) may occur in altered ... Cited by 41 - Related articles - All 5 versions
- Free from Publisher A Avignon, A Sultan, C Piot, D Mariano- … - Diabetes Care, 2007 - Am Diabetes Assoc RESULTS—A total of 92 patients were diagnosed with SMI. Of the six novel
markers, osteoprotegerin was the only one associated with SMI; the relative risk
(RR) of SMI in patients with osteoprotegerin values above the 75th ... Cited by 16 - Related articles - BL Direct - All 5 versions
